Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 22 April 2008

European Journal of Endocrinology 2008;159:81.

DOI: 10.1530/EJE-08-0069
Copyright © 2008 by European Society of Endocrinology
This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
EJE-08-0069v1
159/1/81    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ono, Y.
Right arrow Articles by Itoh, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ono, Y.
Right arrow Articles by Itoh, M.

RESEARCH

Insulinoma cell CaSR influences insulin secretion in a case with concurrent familial hypocalciuric hypercalcemia and malignant metastatic insulinoma.

Yasunaga Ono, Naohisa Oda, Shin Ishihara, Atsushi Shimomura, Nobuki Hayakawa, Atsushi Suzuki, Akihiko Horiguchi, Takao Senda, Shuichi Miyakawa and Mitsuyasu Itoh

Y Ono, Internal Medicine, Fujita Health University School of Medicine, Toyoake, Japan
N Oda, Internal Medicine, Fujita Health University School of Medicine, Toyoake-City, 470-1192, Japan
S Ishihara, Department of Surgery, Fujita Health University School of Medicine, toyoake, Japan
A Shimomura, Department of Anatomy, Fujita Health University School of Medicine, Toyoake, Japan
N Hayakawa, Internal Medicine, Fujita Health University School of Medicine, Toyoake, Japan
A Suzuki, Internal Medicine, Fujita Health University School of Medicine, Toyoake, Japan
A Horiguchi, Department of Surgery, Fujita Health University School of Medicine, toyoake, Japan
T Senda, Department of Anatomy, Fujita Health University School of Medicine, Toyoake, Japan
S Miyakawa, Department of Surgery, Fujita Health University School of Medicine, toyoake, Japan
M Itoh, Internal Medicine, Fujita Health University School of Medicine, Toyoake, Japan

Correspondence: Naohisa Oda, Email: naohisa{at}fujita-hu.ac.jp

Abstract

Context and objective

Arterial stimulation and venous sampling (ASVS) is an important technique for localizing insulinoma. The principle behind ASVS is that insulin secretion is promoted from insulinoma cells by the injection of calcium into the insulinoma-feeding artery. However, the mechanism for ASVS-induced insulin secretion remains unclear. Both insulinoma and familial hypocalciuric hypercalcemia (FHH) are rare diseases. This study reports on a case in which both of these diseases occur concurrently.

Design and Patient

The patient with FHH also suffered from insulinoma. We reasoned that insulin secretion for ASVS is dependent on the calcium sensing receptor (CaSR). AVSV was performed on this patient. The expression of the CaSR protein and corresponding mRNA were confirmed.

Results

No significant changes in the plasma levels of insulin and C-peptide were observed during ASVS. The patient was clinically diagnosed as having FHH. We confirmed that a mutation in the CaSR gene was present in the genomic DNA of this patient and that there were no mutations in the MEN1 gene. In addition, expression of both CaSR mRNA and CaSR protein was confirmed in the insulinoma samples.

Conclusion

These results suggest that the CaSR gene is involved in ASVS-induced insulin secretion.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 European Society of Endocrinology.